5.9 Bendamustine and Alemtuzumab Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia: Interim Report of the Italian Trial
Titel:
5.9 Bendamustine and Alemtuzumab Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia: Interim Report of the Italian Trial
Auteur:
Tedeschi, A. Coscia, M. Rossi, D. Ricci, F. D'arena, G. Orlandi, E. Petrizzi, V. Belsito Scarfò, L. Vitale, C. Vismara, E. Gaidano, G. Morra, E. Massaia, M. Montillo, M.